RICKETTSIOSIS

RICKETTSIOSIS was reported 22 times

RICKETTSIOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimalarial [EPC] 1 0.0001
1 Antiprotozoal [EPC] 1 0.0001
2 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
3 Antimetabolite Immunosuppressant [EPC] 1 0.0000
4 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
5 Phenothiazine [EPC] 1 0.0000
6 Penem Antibacterial [EPC] 1 0.0000
7 Tetracycline-class Drug [EPC] 2 0.0000
8 Integrin Receptor Antagonist [EPC] 2 0.0000
9 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
10 Glycopeptide Antibacterial [EPC] 1 0.0000
11 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
12 Androgen Receptor Inhibitor [EPC] 1 0.0000
13 Nucleoside Analog Antiviral [EPC] 1 0.0000
14 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
15 Interleukin-12 Antagonist [EPC] 1 0.0000
16 Interleukin-23 Antagonist [EPC] 1 0.0000
17 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
18 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
19 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
20 Calcium [EPC] 1 0.0000
21 Aldosterone Antagonist [EPC] 1 0.0000
22 Azole Antifungal [EPC] 1 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
24 Corticosteroid [EPC] 7 0.0000
25 Estrogen [EPC] 1 0.0000
26 Vitamin C [EPC] 2 0.0000
27 Loop Diuretic [EPC] 2 0.0000
28 Progestin [EPC] 1 0.0000
29 Proton Pump Inhibitor [EPC] 2 0.0000
30 Osmotic Laxative [EPC] 1 0.0000
31 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
32 Thalidomide Analog [EPC] 1 0.0000
33 Kinase Inhibitor [EPC] 1 0.0000
34 Platelet Aggregation Inhibitor [EPC] 1 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
36 Benzodiazepine [EPC] 1 0.0000